Key Insights

Highlights

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
Showing all 1 trials

Research Network

Active Sponsors

  • Anglia Ruskin University1
  • Mid and South Essex NHS Foundation Trust1

Related Conditions

  • Ectopia Lentis1
  • Cataract1
  • Marfans Syndrome With Ocular Manifestations1
  • Pseudoexfoliation Syndrome1

Activity Timeline